AZNAstraZenecaRunning, no new patients
MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma
Unresectable Pleural Mesothelioma
0Calmworry score, out of 100
No strong warning signs right now. The score counts warning signs; it is not a prediction.
Why this score
No warning signs right now. That's why the score is 0.
Score over time
- Stage
- Phase 3
- Patients
- 863 (final count)
- Started
- Nov 9, 2023
- Main results expected
- Nov 16, 2028
- Fully finished
- Nov 16, 2028
- Results posted
- not yet
What counts as success
The trial's main goal(s), called the “primary outcome.”
Overall Survival (OS) in experimental arm relative to comparator arm
Measured over: up to approximately 61 months
Changes Tremor has spotted
No changes since Tremor started watching this trial.
Show details (technical version)
Score inputs
- none
Raw record changes
- none yet
Trial ID NCT06097728 · record last updated 2026-10-23 · checked 2026-11-09 15:47 UTC